Validation of a gastric cancer nomogram using a cancer registry

Awais Ashfaq, John T. Kidwell, Lee J. McGhan, Amylou Dueck, Barbara A Pockaj, Richard J. Gray, Sanjay P. Bagaria, Nabil Wasif

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background A Memorial Sloan Kettering (MSKCC) nomogram predicts disease specific survival (DSS) for gastric adenocarcinoma. The goal of this study is to use a cancer registry to compare nomogram predicted survival with actual survival in the general population. Methods All patients undergoing surgery for gastric adenocarcinoma from the Surveillance, Epidemiology, and End Results (SEER) database (1988-2012) were studied. Results 6954 patients were identified. Majority of cancers were in the antrum (30.2%), and had intestinal histology (73.7%). Median follow-up was 8.2 years. Five year DSS for nomogram risk groups (0-25%, 26-50%, 51-75%, and 76-100%) was 23%, 48%, 57%, and 81% respectively. Actual DSS was 7-15% lower than nomogram predicted DSS. Relative to patients in the 76-100% 5-year DSS risk group, patients in the 0-25%, 26-50%, and 51-75% groups had significantly higher risks of death with hazard ratios of 6.84 (95%CI 6.12-7.65), 3.30 (95%CI 2.83-3.86), and 2.64 (95%CI 2.30-3.03), respectively (all P < 0.001). The concordance index for 5-year nomogram predicted DSS was 0.68 (95%CI 0.67-0.69). Conclusions The MSKCC gastric cancer nomogram over-estimates DSS from gastric cancer in the general population and has a moderate concordance index. Predictive tools generated at specialized institutions may not perform as well in the general population. J. Surg. Oncol. 2015; 112:377-380.

Original languageEnglish (US)
Pages (from-to)377-380
Number of pages4
JournalJournal of Surgical Oncology
Volume112
Issue number4
DOIs
StatePublished - Sep 1 2015

Fingerprint

Nomograms
Stomach Neoplasms
Registries
Survival
Neoplasms
Stomach
Adenocarcinoma
Population
Histology
Epidemiology
Databases

Keywords

  • gastric cancer
  • nomograms
  • prognosis
  • registries
  • SEER program
  • validation studies

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Validation of a gastric cancer nomogram using a cancer registry. / Ashfaq, Awais; Kidwell, John T.; McGhan, Lee J.; Dueck, Amylou; Pockaj, Barbara A; Gray, Richard J.; Bagaria, Sanjay P.; Wasif, Nabil.

In: Journal of Surgical Oncology, Vol. 112, No. 4, 01.09.2015, p. 377-380.

Research output: Contribution to journalArticle

Ashfaq, Awais ; Kidwell, John T. ; McGhan, Lee J. ; Dueck, Amylou ; Pockaj, Barbara A ; Gray, Richard J. ; Bagaria, Sanjay P. ; Wasif, Nabil. / Validation of a gastric cancer nomogram using a cancer registry. In: Journal of Surgical Oncology. 2015 ; Vol. 112, No. 4. pp. 377-380.
@article{2548feb3c1234e179bb187dc847df7a2,
title = "Validation of a gastric cancer nomogram using a cancer registry",
abstract = "Background A Memorial Sloan Kettering (MSKCC) nomogram predicts disease specific survival (DSS) for gastric adenocarcinoma. The goal of this study is to use a cancer registry to compare nomogram predicted survival with actual survival in the general population. Methods All patients undergoing surgery for gastric adenocarcinoma from the Surveillance, Epidemiology, and End Results (SEER) database (1988-2012) were studied. Results 6954 patients were identified. Majority of cancers were in the antrum (30.2{\%}), and had intestinal histology (73.7{\%}). Median follow-up was 8.2 years. Five year DSS for nomogram risk groups (0-25{\%}, 26-50{\%}, 51-75{\%}, and 76-100{\%}) was 23{\%}, 48{\%}, 57{\%}, and 81{\%} respectively. Actual DSS was 7-15{\%} lower than nomogram predicted DSS. Relative to patients in the 76-100{\%} 5-year DSS risk group, patients in the 0-25{\%}, 26-50{\%}, and 51-75{\%} groups had significantly higher risks of death with hazard ratios of 6.84 (95{\%}CI 6.12-7.65), 3.30 (95{\%}CI 2.83-3.86), and 2.64 (95{\%}CI 2.30-3.03), respectively (all P < 0.001). The concordance index for 5-year nomogram predicted DSS was 0.68 (95{\%}CI 0.67-0.69). Conclusions The MSKCC gastric cancer nomogram over-estimates DSS from gastric cancer in the general population and has a moderate concordance index. Predictive tools generated at specialized institutions may not perform as well in the general population. J. Surg. Oncol. 2015; 112:377-380.",
keywords = "gastric cancer, nomograms, prognosis, registries, SEER program, validation studies",
author = "Awais Ashfaq and Kidwell, {John T.} and McGhan, {Lee J.} and Amylou Dueck and Pockaj, {Barbara A} and Gray, {Richard J.} and Bagaria, {Sanjay P.} and Nabil Wasif",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/jso.23999",
language = "English (US)",
volume = "112",
pages = "377--380",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Validation of a gastric cancer nomogram using a cancer registry

AU - Ashfaq, Awais

AU - Kidwell, John T.

AU - McGhan, Lee J.

AU - Dueck, Amylou

AU - Pockaj, Barbara A

AU - Gray, Richard J.

AU - Bagaria, Sanjay P.

AU - Wasif, Nabil

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background A Memorial Sloan Kettering (MSKCC) nomogram predicts disease specific survival (DSS) for gastric adenocarcinoma. The goal of this study is to use a cancer registry to compare nomogram predicted survival with actual survival in the general population. Methods All patients undergoing surgery for gastric adenocarcinoma from the Surveillance, Epidemiology, and End Results (SEER) database (1988-2012) were studied. Results 6954 patients were identified. Majority of cancers were in the antrum (30.2%), and had intestinal histology (73.7%). Median follow-up was 8.2 years. Five year DSS for nomogram risk groups (0-25%, 26-50%, 51-75%, and 76-100%) was 23%, 48%, 57%, and 81% respectively. Actual DSS was 7-15% lower than nomogram predicted DSS. Relative to patients in the 76-100% 5-year DSS risk group, patients in the 0-25%, 26-50%, and 51-75% groups had significantly higher risks of death with hazard ratios of 6.84 (95%CI 6.12-7.65), 3.30 (95%CI 2.83-3.86), and 2.64 (95%CI 2.30-3.03), respectively (all P < 0.001). The concordance index for 5-year nomogram predicted DSS was 0.68 (95%CI 0.67-0.69). Conclusions The MSKCC gastric cancer nomogram over-estimates DSS from gastric cancer in the general population and has a moderate concordance index. Predictive tools generated at specialized institutions may not perform as well in the general population. J. Surg. Oncol. 2015; 112:377-380.

AB - Background A Memorial Sloan Kettering (MSKCC) nomogram predicts disease specific survival (DSS) for gastric adenocarcinoma. The goal of this study is to use a cancer registry to compare nomogram predicted survival with actual survival in the general population. Methods All patients undergoing surgery for gastric adenocarcinoma from the Surveillance, Epidemiology, and End Results (SEER) database (1988-2012) were studied. Results 6954 patients were identified. Majority of cancers were in the antrum (30.2%), and had intestinal histology (73.7%). Median follow-up was 8.2 years. Five year DSS for nomogram risk groups (0-25%, 26-50%, 51-75%, and 76-100%) was 23%, 48%, 57%, and 81% respectively. Actual DSS was 7-15% lower than nomogram predicted DSS. Relative to patients in the 76-100% 5-year DSS risk group, patients in the 0-25%, 26-50%, and 51-75% groups had significantly higher risks of death with hazard ratios of 6.84 (95%CI 6.12-7.65), 3.30 (95%CI 2.83-3.86), and 2.64 (95%CI 2.30-3.03), respectively (all P < 0.001). The concordance index for 5-year nomogram predicted DSS was 0.68 (95%CI 0.67-0.69). Conclusions The MSKCC gastric cancer nomogram over-estimates DSS from gastric cancer in the general population and has a moderate concordance index. Predictive tools generated at specialized institutions may not perform as well in the general population. J. Surg. Oncol. 2015; 112:377-380.

KW - gastric cancer

KW - nomograms

KW - prognosis

KW - registries

KW - SEER program

KW - validation studies

UR - http://www.scopus.com/inward/record.url?scp=84942292978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942292978&partnerID=8YFLogxK

U2 - 10.1002/jso.23999

DO - 10.1002/jso.23999

M3 - Article

C2 - 26271201

AN - SCOPUS:84942292978

VL - 112

SP - 377

EP - 380

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -